Department of Medical Oncology, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Department of Medical Oncology, Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Lab Invest. 2023 Aug;103(8):100174. doi: 10.1016/j.labinv.2023.100174. Epub 2023 May 9.
We developed a comprehensive method for functional assessment of the changes in immune populations and killing activity of peripheral blood mononuclear cells after cocultures with cancer cells using mass cytometry. In this study, a 43-marker mass cytometry panel was applied to a coculture of immune cells from healthy donors' peripheral blood mononuclear cells with diverse cancer cell lines. DNA content combined with classical CD45 surface staining was used as gating parameters for cocultures of immune cells (CD45/DNA) with hematological (CD45/DNA) and solid cancer cell lines (CD45/DNA). This strategy allows for universal discrimination of cancer cells from immune populations without the need for a specific cancer cell marker and simultaneous assessment of phenotypical changes in both populations. The use of mass cytometry allows for simultaneous detection of changes in natural killer, natural killer T cell, and T cell phenotypes and degranulation of immune populations upon target recognition, analysis of target cells for cytotoxic protein granzyme B content, and cancer cell death. These findings have broad applicability in research and clinical settings with the aim to phenotype and assess functional changes following not only NK-cancer cell interactions but also the effect of those interactions on other immune populations.
我们开发了一种综合方法,用于使用液质联用技术评估与癌细胞共培养后外周血单个核细胞中免疫群体的功能变化和杀伤活性。在这项研究中,我们应用了一个包含 43 种标志物的液质联用面板,对来自健康供体外周血单个核细胞的免疫细胞与多种癌细胞系的共培养进行分析。DNA 含量结合经典的 CD45 表面染色被用作免疫细胞(CD45/DNA)与血液(CD45/DNA)和实体癌细胞系(CD45/DNA)共培养的门控参数。这种策略允许在不需要特定的癌细胞标记物的情况下,普遍区分癌细胞和免疫群体,并同时评估两个群体的表型变化。液质联用技术的应用允许同时检测自然杀伤细胞、自然杀伤 T 细胞和 T 细胞表型的变化以及免疫群体在靶标识别时的脱颗粒,分析靶细胞中细胞毒性蛋白颗粒酶 B 的含量,以及癌细胞的死亡。这些发现具有广泛的适用性,无论是在研究还是临床环境中,都可以用于表型分析和评估不仅在 NK-癌细胞相互作用后,而且在这些相互作用对其他免疫群体的影响后的功能变化。